share_log

HC Wainwright & Co. Maintains Buy on Ensysce Biosciences, Lowers Price Target to $7

HC Wainwright & Co. Maintains Buy on Ensysce Biosciences, Lowers Price Target to $7

HC Wainwright & Co.維持對Ensysce Biosciences的買入,將目標價下調至7美元
Benzinga ·  2023/09/25 06:12

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Ensysce Biosciences (NASDAQ:ENSC) with a Buy and lowers the price target from $9 to $7.

HC Wainwright&Co.分析師Raghuram Selvaraju維持Ensysce Biosciences(納斯達克:ENSC)的買入,並將目標價從9美元下調至7美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論